Entrada Therapeutics, Inc.

Q4 2024 13F Holders

Symbol
TRDA
CUSIP
29384C108
Type
Equity
Class
COM
Num filings
109
Total reported value, excl. options
$530 M
Manager Report Date Value ($000) Shares Option Type